Apoptotic-cell-bound beta 2-glycoprotein I (beta 2GPI), but not apoptotic c
ells or beta 2GPI alone, can induce the production of anti-phospholipid (an
ti-PL) antibodies (Ab) in normal mice. Although it is presumed that beta 2G
PI binds to anionic phospholipid (PL) exposed on the apoptotic cell membran
e, the precise nature of this complex and its immunogenicity is unclear. To
address these issues, we investigated the structure and immunogenicity of
human beta 2GPI in the presence of different PL that may be expressed on th
e surface of apoptotic cells. BALB/c mice were immunized intravenously (iv)
with beta 2GPI in the presence of cardiolipin (CL), phosphatidylglycerol (
PG), phosphatidylserine (PS), phosphatidylcholine (PC), or PS/PC (25%/75%)
vesicles. Cardiolipin+beta 2GPI induced the highest levels of anti-beta 2GP
I and anti-CL IgG Ab and lupus anticoagulant (LA) activity, while beta 2GPI
with PC or PS/PC vesicles produced no significant anti-PL Ab. PS+beta 2GPI
was somewhat immunogenic, but less so than PG+beta 2GPI. beta 2GPI was imm
unogenic in the presence of native (CLN), but not hydrogenated (CLH), CL. C
ircular dichroism analysis demonstrated that the structure of beta 2GPI was
altered specifically by interaction with CLN, but not other anionic PL, in
cluding CLH. Similarly, the structure of CLN was affected by interaction wi
th beta 2GPI, as detected by P-31 nuclear magnetic resonance. These finding
s demonstrate that beta 2GPI complexed with CLN is structurally altered, hi
ghly immunogenic, and induces the production of IgG anti-PL Ab. Furthermore
, the structural modification and the generation of immunogenic epitopes on
beta 2GPI upon interaction with CLN require the presence of unsaturated fa
tty acid chains, suggesting a role for oxidation in this process. (C) 2000
Academic Press.